Skip to content

Johnson and Johnson Janssen COVID-19 Vaccine

Community & News, Service Line
March 03, 2021
Johnson and Johnson Janssen COVID-19 Vaccine

While many who have yet to receive a COVID-19 vaccine eagerly anticipate an opportunity to receive one, many still have questions. This video from TriHealth addresses the Johnson & Johnson Janssen vaccine, the most recent vaccine to be approved for use in the U.S., and a one which utilizes different technology than the previous versions from the mRNA Pfizer and Moderna. Topics include:

  • A reminder of how the previous vaccines use mRNA technology to help your body build immunity to the disease
  • How an Ad Vector vaccine mimics a natural infection to stimulate an immune response so your body can identify and destroy the COVID-19 Coronavirus
  • Background on the development and trials for Ad Vector technology
  • Differences between the Johnson & Johnson Janssen vaccine including stability and dosing and how those are beneficial
  • A list of ingredients in the new vaccine
  • Data on efficacy based on trials for the vaccine and why comparisons to the other vaccines aren’t necessarily valid due to timing and the emergence of COVID-19 variants, which impacted trials for the new vaccine
  • Positive data on the frequency and severity of symptoms for vaccinated participants in the study versus those who received a placebo
  • Common side effects and symptoms following the vaccine
  • A look at the diversity of the Johnson & Johnson Janssen study sample
  • Why you should take whichever vaccine you are able to get first


Related Articles